Peter Thiel
Known title: DirectorCIK: 0001211060
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Chemomab Amends Merger Agreement for U.S. Redomiciliation. Chemomab has amended its merger agreement to facilitate a U.S. redomiciliation and combination with Scipher. This corporate restructuring is a significant development for the company's structure. The stock is currently trading near its 52-week low, reflecting the ongoing uncertainty surrounding these changes.
Transaction History
| PLTR | ▼ Sell | Open Market | 222,837 | $31.9M | 3/2/2026 | View on chart |
| PLTR | ▼ Sell | Open Market | 419,113 | $60.4M | 3/2/2026 | View on chart |
| PLTR | ▼ Sell | Open Market | 721,136 | $104.7M | 3/2/2026 | View on chart |
| PLTR | ▼ Sell | Open Market | 488,783 | $71.4M | 3/2/2026 | View on chart |
| PLTR | ▼ Sell | Open Market | 51,383 | $7.5M | 3/2/2026 | View on chart |
| PLTR | ▼ Sell | Open Market | 50,026 | $7.1M | 3/2/2026 | View on chart |
| PLTR | ▼ Sell | Open Market | 46,722 | $6.6M | 3/2/2026 | View on chart |
| PLTR | ▼ Sell | Open Market | 3,350,229 | $122.4M | 10/1/2024 | View on chart |
| PLTR | ▼ Sell | Open Market | 891,771 | $33.2M | 10/1/2024 | View on chart |
| PLTR | ▼ Sell | Open Market | 3,144,945 | $115.8M | 9/30/2024 | View on chart |
| PLTR | ▼ Sell | Open Market | 1,036,173 | $38.6M | 9/30/2024 | View on chart |
| PLTR | ▼ Sell | Open Market | 3,989,204 | $147.4M | 9/27/2024 | View on chart |
| PLTR | ▼ Sell | Open Market | 4,561,502 | $169.1M | 9/26/2024 | View on chart |
| PLTR | ▼ Sell | Open Market | 4,254,666 | $156.4M | 9/25/2024 | View on chart |
| PLTR | ▼ Sell | Open Market | 7,214,637 | $265.9M | 9/24/2024 | View on chart |
| PLTR | ▼ Sell | Open Market | 147,610 | $5.6M | 9/24/2024 | View on chart |
| PLTR | ▼ Sell | Open Market | 5,000,000 | $103.9M | 5/10/2024 | View on chart |
| PLTR | ▼ Sell | Open Market | 1,669,411 | $35.5M | 5/9/2024 | View on chart |
| PLTR | ▼ Sell | Open Market | 6,285,833 | $134.1M | 5/8/2024 | View on chart |
| PLTR | ▼ Sell | Open Market | 6,914,475 | $171.3M | 3/12/2024 | View on chart |
| PLTR | ▼ Sell | Open Market | 130,281 | $3.3M | 3/12/2024 | View on chart |
| PLTR | ▼ Sell | Other | 3,330,804 | $0 | 11/14/2023 | View on chart |
| CMMB | ▲ Buy | Open Market | 230,536 | — | 3/16/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Palantir shares fall as software sector sheds $260 billion
Palantir stock is declining alongside other major software companies like Okta and Datadog, contributing to a sector-wide loss of $260 billion. This pullback causes the stock to retreat from its recent record highs, a move that aligns with its high-beta trading behavior. While the average analyst target remains significantly higher than current prices, the broad market weakness is currently driving the stock lower.
Palantir shares fall as software sector sheds $260 billion. Palantir stock is declining alongside other major software companies like Okta and Datadog, contributing to a sector-wide loss of $260 billion. This pullback causes the stock to retreat from its recent record highs, a move that aligns with its high-beta trading behavior. While the average analyst target remains significantly higher than current prices, the broad market weakness is currently driving the stock lower.